Processa Pharmaceuticals Inc (PCSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -4,520 | N/A | N/A | N/A |
| Depreciation Amortization | 420 | N/A | N/A | N/A |
| Accounts receivable | 18 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 77 | N/A | N/A | N/A |
| Other Working Capital | -250 | N/A | N/A | N/A |
| Other Operating Activity | 1,565 | 0 | 0 | 0 |
| Operating Cash Flow | $-2,690 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -10 | N/A | N/A | N/A |
| Other Investing Activity | -30 | 0 | 0 | 0 |
| Investing Cash Flow | $-40 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Change In Short Term Borrowing | 2,244 | N/A | N/A | N/A |
| Debt Repayment | -46 | N/A | N/A | N/A |
| Common Stock Issued | 366 | N/A | N/A | N/A |
| Other Financing Activity | 5 | 0 | 0 | 0 |
| Financing Cash Flow | $2,570 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 180 | N/A | N/A | N/A |
| End Cash Position | 20 | N/A | N/A | N/A |
| Net Cash Flow | $-160 | $N/A | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -2,690 | N/A | N/A | N/A |
| Capital Expenditure | -11 | N/A | N/A | N/A |
| Free Cash Flow | -2,701 | 0 | 0 | 0 |